{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-25-001733","form_type":"8-K","ticker":"UTMD","cik":"0000706698","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.946589+00:00","generated_at":"2026-05-17T00:45:43.323878+00:00","sec_items":["5.02","8.01","9.01","99.1"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Utah Medical Products appoints director, increases quarterly dividend to $0.31/share","bullets":["Appointed Kevin Timken to board, increasing size to 6; he joins Audit and Compensation committees.","Timken received 10,000 stock options at $58.10, vesting over 4 years; quarterly fee $7,650 pro-rated.","Quarterly cash dividend raised to $0.31 per share, payable Jan 5, 2026 to holders of record Dec 16, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-25-001733","json":"https://secwatch.observer/filing/0001096906-25-001733.json","markdown":"https://secwatch.observer/filing/0001096906-25-001733.md","text":"https://secwatch.observer/filing/0001096906-25-001733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/706698/000109690625001733/0001096906-25-001733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/706698/000109690625001733/utmd-20251104_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:45:43.323878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}